Fig. 3.
Distribution of individual VEGF suppression times of patients with nAMD treated with ranibizumab, as reported in Muether et al. [89]
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.